SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-06
👔
CORCEPT THERAPEUTICS INC
@CORT_InsiderForm 4 Filing: Guyer William Sells $498,666.76 of $CORT
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
CORCEPT THERAPEUTICS INC
Ticker: $CORT
Transaction Value
$498,666.76
Price/Share: $67.39
transaction date
2026-08-04
Shares: 7,400
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Guyer William, holds the title of Chief Development Officer at CORCEPT THERAPEUTICS INC.
On 2026-08-04, the insider transacted 7,400 shares.The shares were transacted at a weighted average price of $67.39 per share, resulting in a total market-relevant value of $498,666.76.
Executive Summary Summary
Guyer William (Chief Development Officer) sold $499K of $CORT
Post-Transaction Position: 3,985 shares
SEC Accession No: 0001193125-26-338637 (CIK: 1879013)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.